1
In this review, we provide a summary of the recent advances in the field of germ cell specification in mice. We briefly discuss the signals, transcription factors, and epigenetic reprogramming involved in mouse PGC specification. In addition, we describe in vitro PGC induction in mouse and humans using pluripotent stem cells. Conversely, understanding the process of germline specification in vivo is critical to providing a strong foundation for successful reconstitution of PGCs in vitro. Robust in vitro PGC induction in mice and humans could potentially aid our understanding of the germline specification process in vivo and lead to advances in reproductive and regenerative medicine.
Mammalian Germline Induction by Extrinsic Signals
be identified by their alkaline phosphatase (AP) activity during early gastrulation. By 7.25 days post-coitum (dpc), these AP-positive cells increase in number to approximately 40 cells and are visible as a cluster at the base of the incipient allantois. 5, 6 Subsequently, these cells start to move from the posterior primitive streak to the embryonic endoderm, where they become motile and migrate en masse through the hindgut mesentery toward the future genital ridge to colonize the gonad by around 10.0 dpc. Following their arrival into the genital ridge, the germ cells undergo morphological changes, such as the loss of polarized morphology and motility, and are thereafter referred to as gonocytes. Subsequently, gonocytes proliferate and start their sex-specific development.
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Induction of mouse PGC specification in a subset of epiblast cells is dependent on signals from the surrounding extraembryonic ectoderm (ExE) and visceral endoderm (VE) of the developing embryo 3, 8, 9 (►Fig. 1). 
17
In addition to BMP, WNT signaling is also essential for PGC specification. Targeted deletion of Wnt3 and Ctnnb1 (encodes for β-catenin, the downstream signal transducer of WNT) results in a complete absence of PRDM1-positive PGCs by 7.0 dpc in mutant embryos.
3,9 WNT3 is expressed in both the posterior VE and the epiblast of the developing embryo at 6.25 dpc. 18 Later, WNT3 expression becomes restricted to the posterior proximal epiblast and posterior VE. Expression of WNT3 is important for inducing expression of primitive steak genes required for gastrulation at around 5.5 to 6.5 dpc. 18 These mesodermal genes are expressed in PGC precursors, but their expression is repressed in PGCs by 7.5 dpc to maintain the germ cell fate. However, some mesodermal factors activated by WNT3 signaling such as mesodermal factor T (encoded by the brachyury gene) have been shown to be required for PGC specification.
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How WNT3 and BMP signaling coordinate the induction of germ cells is not clear. BMP signaling components were expressed in the ExE of WNT3 null embryos; however, active BMP signaling, as indicated by the presence of phosphorylated SMAD1/5/8, was absent in mutant embryos.
3 Thus, one possibility is that WNT signaling might be important to make the epiblast competent to respond to BMP signaling for PGC specification. The role of Nodal signaling in the induction of germ cell fate has not been investigated; however, Bmp4 and Wnt3 expression is absent or reduced in Nodal-null embryos, suggesting that Nodal signaling might play a crucial role in PGC specification.
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The specified PGCs are restricted to the posterior epiblast by inhibitory signals emitted from the anterior visceral endoderm (AVE). These signals include CER1 (a BMP antagonist encoded by the cerberus 1 gene) that inhibits BMP signaling; LEFTY1 that inhibits Nodal signaling; and DKK1 (a WNT3 antagonist encoded by the dickkopf 1 gene) that inhibits WNT signaling in the anterior epiblast.
3 Hence, BMP, Nodal, and WNT signals are restricted to the posterior side of the embryo, thereby creating an environment for the PGC cluster to remain distinct from the somatic cell lineages. Prdm14, and Tcfap2c results in failure of proper PGC specification in mutant embryos, highlighting the importance of these transcription factors in germ cell specification and maintenance. 16, 22, 23 In addition to suppressing the somatic program, PRDM1 and PRDM14 are important for upregulating the expression of germ-cell-specific genes and pluripotency genes in PGC precursors. 25 Furthermore, studies have shown that they are also required for initiating the process of epigenetic reprogramming, such as repressing the expression of euchromatic histone methyltransferase 1 (EHMT1), an enzyme that catalyzes the addition of methyl groups to H3K9 (H3K9me1 and H3K9me2), and DNMT3A and DNMT3B enzymes that perform de novo DNA methylation. 16, 21, 22 Overexpression of Prdm14 alone or any two of the three transcription factors (PRDM1, PRDM14, or TCFAP2C) induced mouse PGC-like cells (mPGCLCs) from mouse epiblast-like cells (mEpiLCs) in culture.
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It has been shown that PRDM1 mainly binds to promoter regions of genes, with histone modifiers such as HDAC2, EHMT1, protein arginine N-methyltransferase PRMT5, and histone lysine demethylase 1A (KDM1A). 34 In all, PRDM1, PRDM14, and TCFAP2C form a transcription factor network that influences epigenetic modifiers and complexes to regulate the process of PGC specification.
Pluripotency Factors and Germ Cell Induction
In addition to suppression of the somatic program and expression of germ-cell-specific genes, PGCs express pluripotency genes, such as Pou5f1 (also known as Oct4), Sox2, Klf2, and Dppa3 (also known as Stella). Gene knockout/knockdown studies have revealed that Dppa3 and Klf2 are dispensable for PGC development, but Oct4, Nanog, and Sox2 are required for PGC development. [35] [36] [37] [38] POU5F1 is expressed throughout the postimplantation epiblast and in PGCs during specification. 39, 40 Its expression continues at high levels in germ cells until sexual differentiation ensues in the developing gonad. Expression of NANOG is seen in the posterior proximal epiblast, the region where PGCs are specified in 6.5 and 7.5 dpc embryos. Shorthairpin RNA-mediated conditional knockdown of Nanog in PGCs results in apoptosis of migrating PGCs and loss of PGCs by 12.5 dpc, indicating that Nanog is dispensable for PGC specification but is absolutely essential for PGC maintenance.
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SOX2 expression in PGCs is detected at 7.5 dpc embryos onward. Conditional deletion of Sox2 in the PGCs shortly after specification at 7.5 dpc leads to significant decrease in germ cell number; by 13.5 dpc, germ cells are not detected. 38 SOX2 regulates expression of Kit, the latter of which regulates PGC survival and proliferation, providing a link between Sox2 function and PGC maintenance. 38 Recently, it was reported that in vitro overexpression of Nanog alone in mEpiLCs, but not Pou5f1 or Sox2, was able to induce germ cell fate by directly activating Prdm1 and Prdm14 enhancers independent of BMP4. 41 Loss of Nanog, on the other hand, impaired the induction of mPGCLCs by BMP4. 41 These studies indicate that NANOG and BMP4 might cooperate to induce germ cell fate in vivo.
Epigenetic Reprogramming during Mouse PGC Specification
During mammalian development, epigenetic reprogramming occurs in two phases: the first one occurs after fertilization in the zygote, and the second one occurs during early germline development. 42, 43 Reprogramming during the preimplantation phase serves to reset the epigenome of the zygote by erasing the epigenetic marks acquired from the gametes (except the marks on the imprinted loci), so as to allow for totipotency to be acquired. Reprogramming in the early germline serves to erase the parental epigenetic memory, thereby facilitating the process of germ cell development. 42, 43 In this section, we discuss the major epigenetic reprogramming events that occur during PGC specification.
Global DNA Demethylation in the Early Germline
Following specification and as they start to migrate and colonize the genital ridges, PGCs undergo extensive In
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genome-wide epigenetic reprogramming, such as DNA demethylation, 44 erasure of paternal imprints, 44 and reactivation of the inactive X chromosome. [45] [46] [47] [48] Global DNA methylation levels drop from 70% in PGC precursors in the posterior epiblast to 4% in 13.5 dpc PGCs. 49, 50 The entire genome, including imprinted regions, is hypomethylated at this stage. In males, sex-specific methylation patterns are reestablished immediately after 13.5 dpc; however, reestablishment of methylation patterns occurs after birth in female PGCs. 43 The mechanism of global demethylation in the early germline is thought to be a passive process. PRDM1 and PRDM14 directly or indirectly repress the expression of DNMT3A and DNMT3B (enzymes which mediate de novo DNA methylation) as well as UHRF1, a recruitment factor for DNMT1 (an enzyme that mediates maintenance DNA methylation). 21, 22 Thus, both de novo methylation and maintenance of methylation are repressed, leading to passive loss of DNA methylation following rounds of DNA replication as the PGCs proliferate.
49,51-53
Recently, it has been shown that loss of DNA methylation in early PGCs could partly occur via active DNA demethylation, especially at imprinted loci that are protected from DNA demethylation, by the time the PGCs settle in the genital ridge at around 9.5 to 10.5 dpc. 54 The Tet methylcytosine dioxygenases TET1 and TET2 (enzymes responsible for conversion of 5-methylcytosine to 5-hydroxymethylcytosine) are upregulated at 9.5 to 11.5 dpc, concomitant with increased levels of 5-hydroxymethylcytosine (5hmC) and decreased levels of 5-methylcytosine (5mC) seen in PGCs. 55 Despite these findings, gene knockout studies clearly suggested that global DNA demethylation of the early germline occurs passively, except for the imprinted loci and promoters of genes involved in meiosis during germ cell differentiation.
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Reorganization of Histone Marks during Germline Specification
In addition to DNA demethylation, PGCs undergo reorganization of chromatin modifications. It has been reported that 60% of migrating PGCs between 8.0 and 9.0 dpc are in the G2 phase of the cell cycle.
59 PRDM1
might play an important role in this G2 arrest, as PRDM1 is known to suppress expression of S-phase-promoting factors such as Ccne1, Ccnd1, Cdc25a, Cdc6, Pold2, E2F3, and Myc.
21
PGCs during this period also pause RNA-polymerase II-mediated transcription. 59 Thus, by repression of active epigenetic enzymes, arresting in the G2 phase of cell cycle, and pausing of RNA-polymerase II-mediated transcription, PGCs acquire a unique cellular state for epigenetic reprogramming during the specification process.
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Additionally, there is upregulation of histone H4 arginine 3 dimethylation (H4R3me2) during PGC specification. 63 This methylation is catalyzed by the arginine methyltransferase PRMT5. PRDM1 forms a complex and colocalizes with PRMT5 in the nuclei of migrating PGCs. 63 The colocalization of PRDM1 and PRMT5 in the PGC nuclei was observed between 8.5 and 10.5 dpc. Subsequently, the two proteins translocate to the cytoplasm coincident with the downregulation of H4R3me2 in PGCs. 63, 64 The functional significance of the PRDM1/PRMT5 association as a complex in PGC specification is not well understood and needs further study. In summary, PGC specification in the developing mouse embryo involves at least three key events: suppression of the somatic program, reacquisition of pluripotency, and reprogramming to a unique epigenetic state.
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In Vitro Derivation of Germ Cells from Pluripotent Stem Cells
In vitro derivation of germ cells from pluripotent stem cells has served as a powerful tool to understand the molecular mechanisms (signaling, transcriptional control, and epigenetic regulation) of germline specification not only in mice but also in humans, which ultimately has implications for restoring reproductive capacity. Hence, there is increasing interest in the area of in vitro PGC induction. Initial attempts to reconstitute germ cell specification in culture involved spontaneous differentiation of mouse ECSs to germ-cell-like cells. [65] [66] [67] [68] However, this method was met with little success owing to the very low efficiency of germ cell generation. Later, Ohinata and colleagues 3 isolated mouse epiblast cells and efficiently induced them to become PRDM1-positive and PRDM14-positive PGC-like cells under defined conditions following stimulation by cytokines and BMP4. Furthermore, these cells were able to undergo spermatogenesis following transplantation into neonatal testes of germ-cell-deficient (W/ W v ) mice. 3 However, the ability of epiblast cells to form PGClike cells was shown to be transient. In other studies, a subset of pluripotent stem cells derived from the epiblast, also called epiblast stem cells (EpiSCs), was able to express germ cell markers, but with very low efficiency in culture. In light of these findings, it was speculated that since PGCs are specified from 5.75 to 6.25 dpc, EpiSCs derived from postimplantation embryos would be germline competent. 69 However, only very few (1.5%) of the postimplantation EpiSCs were able to become primordial germ-cell-like cells (PGCLCs), indicating a germcell-incompetent pluripotent state of EpiSCs.
69
To achieve robust PGCLC induction, a germline-competent pluripotent epiblast-like state was recently established in vitro. 70 This reconstitution of mouse PGC specification involves a two-step model (►Fig. 2a). Naive embryonic stem cells (ESCs) from the 3.5-to 4.5-dpc preimplantation embryo (under basal culture conditions consisting of leukemia inhibitory factor [LIF], glycogen synthase kinase β inhibitor [GSK3βi], and inhibitors of extracellular signal-regulated kinases ERK1 and ERK2) are able to give rise to self-renewing ESCs. 70 These ESCs are then primed to become epiblast-like cells (EpiLCs) following addition of Activin A and fibroblast growth factor 2 (FGF2) for 2 days. These cells are transcriptionally similar to 5.75 dpc pre-gastrulation epiblast cells. These EpiLCs are germline-competent, like their in vivo counterparts, and robustly give rise to PGCLCs following addition of BMP4, BMP8b, LIF, stem cell factor (SCF, also known as Kit ligand/KITL), and epidermal growth factors.
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Day 6 PGCLCs and in vivo migratory PGCs have virtually identical transcriptomic and epigenetic profiles. 70 Furthermore, it was shown that XY PGCLCs were able to mature into functional sperm following transplantation into the seminiferous tubules of neonatal germ cell deficient mice (W/W v ).
Intracytoplasmic sperm injection of PGCLC-derived sperm into oocytes yielded healthy fertile offspring, while XX PGCLCs were able to mature into functional oocytes following transplantation into the ovarian bursa of adult mice.
In vitro induction of PGCs in humans has been challenging mainly because human pluripotent stem cells (hPSCs) are in a primed pluripotency state rather than a naive pluripotency state like mouse PSCs. Hence, hPSCs are similar to mEpiSCs with little germ cell competence. Second, knowledge regarding human PGC specification is limited due to difficulty and ethical challenges involved in analyzing the early human embryo. Despite these challenges, various groups have attempted to induce human PGCs in culture (►Fig. 2b). Initial attempts included spontaneous differentiation of human ESCs (hESCs) into PGCLCs, but at very low frequency (5%), indicating low germline competence. [71] [72] [73] [74] Subsequently, several studies have reported the establishment of culture conditions conducive to establishment of naive hESCs. 75, 76 It was shown that hESCs grown in a four-inhibitor (4i) media (composed of transforming growth factor β1 [TGFβ1], FGF2, and LIF, along with inhibitors of ERK1/ERK2, GSK3β, and JUN amino-terminal kinase (JNK) and mitogen-activated kinase p38) were able to respond directly to BMP2 and BMP4 and give rise to human PGCLCs with up to 50% efficiency after 4 to 5 days. 77 These cells have similar transcriptional profiles to human PGCs in vivo. hESCs grown in 4i media have a more similar transcriptome profile to primed hESCs than to the naive pluripotent stem cells from the preimplantation epiblast. [78] [79] [80] The reason for this difference is thought to be the upregulation of mesodermal genes such as T, Mix paired-like homeobox (MIXL1), runt-related transcription factor 1 (RUNX1), and platelet-derived growth factor receptor α (PDGFRA) in hESCs grown in 4i media, possibly resulting in higher germ cell competence. 74 Subsequently, two independent reports demonstrated that cells with early mesodermal In Vivo and In Vitro Studies of Primordial Germ Cell Specification Kumar, DeFalco 143 character have higher propensity toward human PGC specification. 81, 82 In one of these reports, it was demonstrated that when human-induced pluripotent cells (hiPSCs) were differentiated into human incipient mesoderm-like cells (hiMeLCs), they were able to give rise to PRDM1-and TCFAP2C-positive cells with an efficiency of 40% following exposure to BMP2 or BMP4. 81 These hiMeLCs expressed early mesoderm genes like hESCs grown in 4i culture media. These studies indicate that perhaps human PGCs originate from mesoderm precursors and not from the preimplantation epiblast as in mice. PGC specification from the mesoderm occurs in other organisms such as crickets and axolotls, indicating that this phenomenon is potentially well conserved. 2, 4 In mice, mesodermal factors such as T also play an essential role in regulating the expression of important PGC specification factors.
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Significance and Conclusion
In recent years, extensive research into mouse germline specification has led to the identification of key molecular pathways and transcription factors involved in PGC specification. These discoveries include identification of the key signaling pathways BMP and WNT, PRDM1 as a key regulator of PGC specification, and the tripartite transcription factor network (formed by PRDM1, PRDM14, and TCFAP2) required for PGC specification. These studies have formed the basis for reconstitution of the germline lineage in vitro. Despite recent advances in the field, there are still unanswered questions that need further study. For example, the mechanism by which BMP signaling induces PRDM1 expression in the early PGCs is not clear. Additionally, the precise mechanism by which PRDM1 and PRDM14 suppress the somatic program and how epigenetic reprogramming is triggered following PGC specification require further investigation. An in vitro PGC induction model could serve as a valuable tool to answer some of these outstanding questions. Regarding human PGC specification, limited information is available due to difficulty in procuring human embryos and the associated ethical issues. Thus, knowledge gained from in vitro human PGC induction and PGC specification in mice will be essential to understand fully the mechanisms of human PGC specification. Insights gained from research in these fields will have significant implications for understanding reproductive disorders and will help elucidate the origins of germ-cell-related infertility.
